Professor Nef brings several years of international experience in CNS preclinical research and business development from the biotech and pharmaceutical industry. Recently, he served as chief executive officer of Faust Pharmaceuticals, a CNS start-up biotech company headquartered in Strasbourg, France, with a phase II clinical development program and a G protein-coupled receptor technology platform. Professor Nef also served as chief scientific officer and chief business officer of Xytis Inc, a Swiss CNS start-up with a clinical phase II compound for traumatic brain injury. Previously, he was vice-president and global director at Roche Pharma Partnering in Switzerland, where he was in charge of the in-licensing and alliance management for research & technology and early clinical compound assessment in certain disease areas.